CN Patent
CN107987055A — 硫代咪唑二酮类雄激素受体拮抗剂及其用途
Assigned to Individual · Expires 2018-05-04 · 8y expired
What this patent protects
本发明公开了如式(I)的硫代咪唑二酮类化合物,可作为雄激素受体拮抗剂,用于制备治疗雄激素受体相关疾病或紊乱(如癌症等)的药物。
USPTO Abstract
本发明公开了如式(I)的硫代咪唑二酮类化合物,可作为雄激素受体拮抗剂,用于制备治疗雄激素受体相关疾病或紊乱(如癌症等)的药物。
Drugs covered by this patent
- Erleada (apalutamide) · Johnson & Johnson
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.